Orosomucoid 1 Attenuates Doxorubicin‐Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling

Abstract

Doxorubicin (DOX) is an effective anticancer drug, but its therapeutic use is limited by its cardiotoxicity. The principal mechanisms of DOX‐induced cardiotoxicity are oxidative stress and apoptosis in cardiomyocytes. Orosomucoid 1 (ORM1), an acute‐phase protein, plays important roles in inflammation and ischemic stroke; however, the roles and mechanisms of ORM1 in DOX‐induced cardiotoxicity remain unknown. Therefore, in the present study, we aimed to investigate the function of ORM1 in cardiomyocytes experiencing DOX‐induced oxidative stress and apoptosis. A DOX‐induced cardiotoxicity animal model was established in C57BL/6 mice by administering an intraperitoneal injection of DOX (20 mg/kg), and the control group was intraperitoneally injected with the same volume of sterilized saline. The effects were assessed after 7 d. Additionally, H9c2 cells were stimulated with DOX (10 μ M) for 24 h. The results showed decreased ORM1 and increased oxidative stress and apoptosis after DOX stimulation in vivo and in vitro. ORM1 overexpression significantly reduced DOX‐induced oxidative stress and apoptosis in H9c2 cells. ORM1 significantly increased the expression of nuclear factor‐like 2 (Nrf2) and its downstream protein heme oxygenase 1 (HO‐1) and reduced the expression of the lipid peroxidation end product 4‐hydroxynonenal (4‐HNE) and the level of cleaved caspase‐3. In addition, Nrf2 silencing reversed the effects of ORM1 on DOX‐induced oxidative stress and apoptosis in cardiomyocytes. In conclusion, ORM1 inhibited DOX‐induced oxidative stress and apoptosis in cardiomyocytes by regulating the Nrf2/HO‐1 pathway, which might provide a new treatment strategy for DOX‐induced cardiotoxicity.